Insulin Glargine Injection

赛诺菲（北京）制药有限公司🇨🇳 National Medical Products Administration

Approval Id: 8UZLgKAJEAA
Approval Number: 国药准字S20237010
Generic Name: 甘精胰岛素注射液
Generic Name En: Insulin Glargine Injection
Drug Type: 生物制品
Dosage Form: 注射剂
Strength: 1.5ml: 450单位／预填充式注射笔
Reg Date: 2023-10-10
Company Name: 赛诺菲（北京）制药有限公司
Company Address: 北京市北京经济技术开发区兴盛街7号
Production Company Name: 赛诺菲（北京）制药有限公司
Production Company Address: 北京市北京经济技术开发区兴盛街7号
Company Detail Path: /organization/sai-nuo-fei-bei-jing-zhi-yao-you-xian-gong-si
Production Company Detail Path: /organization/sai-nuo-fei-bei-jing-zhi-yao-you-xian-gong-si

Approved

Agency

NMPA

Country

🇨🇳

Approval Date

Oct 10, 2023

Approval ID

8UZLgKAJEAA

Type

生物制品